Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-02

Clinical Trial Update: Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers [NA]

View source ↗

Summary

A completed clinical trial evaluated transcutaneous vagal nerve stimulation for reducing visually induced motion sickness in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wingate Institute of Neurogastroenterology | Conditions: Visually Induced Motion Sickness in Healthy Volunteers | NA | Status: COMPLETED